StockWatch
·
Biotechnology: Pharmaceutical Preparations
AGM/EGMJun 10, 2026, 04:07 PM

PolyPid Schedules AGM/EGM for July 15; Board & CEO Compensation Votes

AI Summary

PolyPid Ltd. announced it will hold its Annual and Extraordinary General Meeting of Shareholders on July 15, 2026, in Petach Tikva, Israel. Shareholders will vote on the re-election of the independent registered public accountants and eight board members, as well as approving their compensation. Additionally, proposals include amending non-executive directors' annual options grants and approving an option grant for CEO Ms. Dikla Czaczkes Akselbrad. The meeting will also include a discussion of the financial statements for the fiscal year ended December 31, 2025.

Key Highlights

  • Annual and Extraordinary General Meeting scheduled for July 15, 2026.
  • Shareholders to re-elect Kost Forer Gabbay & Kasierer as independent auditors.
  • Eight members of the board of directors are up for re-election.
  • Proposal to amend non-executive directors’ annual options grant terms.
  • Proposal to approve an option grant for CEO Dikla Czaczkes Akselbrad.
  • Financial statements for fiscal year ended December 31, 2025, will be discussed.